Frontage Holdings Corp (1521.HK)
Company Info
Highlights
HK$2.31B
HK$0.47 - HK$1.81
HK$1.05
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Frontage Holdings Corp (1521.HK) returned -37.02% year-to-date (YTD) and -7.32% over the past 12 months.
1521.HK
-37.02%
-0.00%
17.53%
-7.32%
-22.75%
N/A
^GSPC (Benchmark)
-3.77%
7.44%
-5.60%
8.37%
14.12%
10.46%
Monthly Returns
The table below presents the monthly returns of 1521.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -6.08% | -27.65% | -0.81% | -4.92% | -1.72% | -37.02% | |||||||
| 2024 | -31.03% | 4.37% | -13.77% | -14.58% | -6.50% | -30.43% | -6.25% | -20.00% | 38.33% | -3.61% | 55.00% | 45.97% | -21.98% |
| 2023 | -4.14% | -6.83% | -8.49% | 2.53% | -11.52% | -6.98% | 15.50% | -4.76% | -7.73% | -3.94% | 9.23% | 8.92% | -20.00% |
| 2022 | -5.06% | -4.00% | -19.72% | -17.99% | 17.30% | 12.59% | -17.89% | 0.39% | -19.38% | -14.90% | 31.07% | 25.00% | -26.58% |
| 2021 | 30.99% | -10.22% | -6.59% | 13.03% | 16.26% | 34.15% | -26.67% | -13.55% | -3.44% | -9.90% | -6.37% | -7.28% | -7.28% |
| 2020 | -11.99% | 23.14% | -34.45% | 13.06% | 14.93% | 17.65% | -14.58% | -2.68% | -13.28% | -1.73% | 8.24% | 15.76% | -3.62% |
| 2019 | -1.79% | -5.17% | 8.65% | 6.49% | 31.58% | 12.00% | -22.18% | 6.76% | 31.94% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 1521.HK is 45, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Frontage Holdings Corp (1521.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Frontage Holdings Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Frontage Holdings Corp was 94.12%, occurring on Oct 17, 2024. The portfolio has not yet recovered.
The current Frontage Holdings Corp drawdown is 86.59%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -94.12% | Jun 29, 2021 | 813 | Oct 17, 2024 | — | — | — |
| -45.44% | Oct 29, 2019 | 107 | Apr 1, 2020 | 200 | Jan 22, 2021 | 307 |
| -41.71% | Feb 4, 2021 | 22 | Mar 9, 2021 | 68 | Jun 18, 2021 | 90 |
| -11.4% | Jul 8, 2019 | 25 | Aug 9, 2019 | 6 | Aug 19, 2019 | 31 |
| -11.04% | May 31, 2019 | 17 | Jun 25, 2019 | 6 | Jul 4, 2019 | 23 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Frontage Holdings Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Frontage Holdings Corp is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for 1521.HK, comparing it with other companies in the Biotechnology industry. Currently, 1521.HK has a P/E ratio of 0.0. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 1521.HK relative to other companies in the Biotechnology industry. Currently, 1521.HK has a P/S ratio of 9.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 1521.HK in comparison with other companies in the Biotechnology industry. Currently, 1521.HK has a P/B value of 0.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |